Autologous infusions of genetically engineered T-cells that express chimeric-antigen receptors might be a promising new treatment for advanced B-cell malignancies. Medscape Medical News
The effects of treatment-induced diarrhea can range from disruptive to deadly, but evidence supports a variety of interventions--some quite simple. Clinical Journal of Oncology Nursing
Does lasofoxifene reduce the risks of both overall and ER+ invasive breast cancer in postmenopausal women with osteoporosis? Journal of the National Cancer Institute
Within the limited landscape of effective chemotherapeutic agents for non-small cell lung cancer, do these new agents deserve further study? Medscape Hematology-Oncology
